Areas of Focus
- Mitochondrial Quality Control
- Parkinson's Disease
- Neurodegeneration
- Cellular Models
- CRISPR/Cas9 Gene Editing
- Neural Differentiation
- Mitochondria-ER Coupling
- Energy Metabolism in Oocytes
- Disease Mechanisms
- Drug Screening
Work Experience
- 2020-05 to Present - Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences - Associate Researcher
- 2016-07 to 2020-05 - Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences - Assistant Researcher
- 2010-09 to 2016-07 - University of Science and Technology of China - PhD Student
- 2006-09 to 2010-07 - Anhui University - Undergraduate Student
Academic Background & Achievements
- 2010-09 to 2016-07 PhD: University of Science and Technology of China
- 2006-09 to 2010-07 Bachelor's: Anhui University
Publications
- Mitolysosome exocytosis: a novel mitochondrial quality control pathway linked with parkinsonism-like symptoms, Feixiang Bao, 2022
- Mitolysosome exocytosis, a mitophagy-independent mitochondrial quality control in flunarizine-induced parkinsonism-like symptoms, Feixiang Bao, 2022
- Autophagy-independent mitochondrial quality control: Mechanisms and disease associations, Feixiang Bao, 2022
- Polybrene induces neural degeneration by bidirectional Ca2+ influx-dependent mitochondrial and ER-mitochondrial dynamics, Feixiang Bao, 2018
- Mitochondrial Membrane Potential-dependent Endoplasmic Reticulum Fragmentation is an Important Step in Neuritic Degeneration, Feixiang Bao, 2016
Awards
- Guangdong Provincial Natural Science Award First Prize (2021): Provincial Level
